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3 months clinical and patient-reported outcomes
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Purpose: To compare refractive and visual outcomes, patient satisfaction, and complication rates 
among different age categories of patients who underwent refractive lens exchange (RLE).
Methods: A stratified, simple random sample of patients matched on preoperative sphere and 
cylinder was selected for four age categories: 45–49 years (group A), 50–54 years (group B), 
55–59 years (group C), and 60–65 years (group D). Each group contained 320 patients. All 
patients underwent RLE with a multifocal intraocular lens at least in one eye. Three months 
postoperative refractive/visual and patient-reported outcomes are presented.
Results: The percentage of patients that achieved binocular uncorrected distance visual acuity 
20/20 or better was 91.6% (group A), 93.8% (group B), 91.6% (group C), 88.8% (group D), 
P=0.16. Binocularly, 80.0% of patients in group A, 84.7% in group B, 78.9% in group C, and 
77.8% in group D achieved 20/30 or better uncorrected near visual acuity (P=0.13). The pro-
portion of eyes within 0.50 D of emmetropia was 84.4% in group A, 86.8% in group B, 85.7% 
in group C, and 85.8% in group D (P=0.67). There was no statistically significant difference 
in postoperative satisfaction, visual phenomena, dry eye symptoms, distance or near vision 
activities. Apart from higher rate of iritis in the age group 50–55 years, there was no statistically 
significant difference in postoperative complication rates.
Conclusion: RLE can be safely performed in younger as well as older presbyopes. No significant 
difference was found in clinical or patient-reported outcomes.
Keywords: refractive lens exchange, multifocal IOLs, younger/older presbyopes
Introduction
Refractive lens exchange (RLE) is a popular surgical modality among presbyopes, 
and it is no longer restricted to only patients with prescriptions outside of limits of 
keratorefractive surgery.1–4 Intraocular lens (IOL) designs have advanced tremendously 
over the past 3 decades,1,2 and more and more patients in presbyopic age range, regard-
less of the amount of preoperative refractive error, seek simultaneous correction of 
distance, intermediate, and near vision.
RLE is often the best surgical option for older presbyopes, as it focuses on the main 
reason for presbyopia development (aging crystalline lens) and prevents formation of 
the cataract in the future.3,4 Some surgeons are, however, cautious about performing 
RLE on younger presbyopes owing to the associated optical side effects and surgical 
risks. In theory, younger presbyopic patients are more active and might have higher 
visual demands. Some optical side effects associated with multifocal IOLs, such as 
glare, halo, loss of contrast sensitivity,1,2 might therefore be more bothersome in this 
group of patients. RLE is also associated with rare but vision-threatening complications, 
Correspondence: steven C schallhorn
11730 Caminito Prenticia, san Diego, 
Ca 92131, Usa
email scschallhorn@yahoo.com 
Journal name: Clinical Ophthalmology
Article Designation: Original Research
Year: 2017
Volume: 11
Running head verso: Schallhorn et al
Running head recto: RLE younger vs older presbyopes
DOI: http://dx.doi.org/10.2147/OPTH.S143201
Clinical Ophthalmology 2017:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1570
schallhorn et al
such as persistent macular edema,4 endopthalmitis5 or retinal 
detachment (RD).6–11 Particularly, RD is one of the main 
concerns in younger myopic patients with longer axial 
lengths,6–11 who have not yet undergone a complete posterior 
vitreous detachment.
As these are valid concerns that deserve investigation, 
we have undertaken a review of younger presbyopic patients 
undergoing RLE in comparison to older patients. In this 
study, we compared visual and refractive outcomes, com-
plication rates, and patient-reported satisfaction among four 
different age categories, ranging between 45 and 65 years.
Patients and methods
This retrospective study was deemed exempt from full review 
by the Committee of Human Research at the University of 
California, San Francisco, because it used only retrospective, 
de-identified patient data. Informed consent to undergo RLE 
and to use de-identified treatment data for research purposes 
and statistical analysis was obtained from all patients.
Outcomes of patients in four age categories (group A: 
45–49 years, group B: 50–54 years, group C: 55–59 years and 
group D: 60–65 years) who underwent RLE with an implanta-
tion of a multifocal lens at least in one eye (Lentis Mplus, Ocu-
lentis GmbH, Berlin, Germany) were compared in this study. 
For each age category, a stratified, simple random sample of 
320 patients, designed to reduce selection bias, was extracted 
from the electronic database of Optical Express (Glasgow, 
UK), a large European provider of refractive surgery. All four 
samples were matched on preoperative sphere and cylinder. 
The following data extraction criteria were used: preoperative 
corrected distance visual acuity (CDVA) 20/20 or better in 
each eye; preoperative ametropia with patient dependent on 
both distance and near correction; attendance of the 3 months 
clinical examination and completion of a postoperative patient 
experience questionnaire. Exclusion criteria were a history of 
glaucoma or RD, corneal disease, previous ocular surgery, 
ocular inflammation, neuro-ophthalmic disease, macular 
degeneration or retinopathy. Patients younger than 50 years 
with axial length over 26 mm were preoperatively referred to a 
vitreoretinal specialist for a complete retinal exam to exclude 
the presence of retinal pathology that would increase the risk 
of a RD. All patients underwent the procedure for refractive 
reasons and did not have cataract.
Preoperative examination included detailed ophthalmic 
examination with manifest and cycloplegic refraction, uncor-
rected distance visual acuity (UDVA), CDVA, uncorrected 
near visual acuity (UNVA), slit-lamp evaluation, dilated 
fundoscopy, autorefraction and tonometry (Tonoref II; Nidek 
Co. Ltd., Gamagori, Japan), corneal topography (Pentacam; 
Oculus, Inc., Wetzlar, Germany), endothelial cell count 
(SP 2000P specular microscope; Topcon Europe BV, Capelle 
aan den Ijssel, the Netherlands), biometry (IOLMaster; Carl 
Zeiss Meditec AG, Jena, Germany) and retinal optical coher-
ence tomography (Cirrus 4000 OCT; Carl Zeiss Meditec 
AG). In patients who were found to be candidates for either 
laser vision correction or an RLE procedure, it was their 
preference that determined the procedure type. Patient prefer-
ence for RLE was primarily driven by their desire to have a 
procedure which would eliminate a future cataract.
Visual acuity was measured at distance with a Snellen 
visual acuity chart and at 40 cm (near) with a logarithmic near 
visual acuity chart (Early Treatment Diabetic Retinopathy 
Study). Near visual acuity was recorded in Snellen distance 
equivalent (meters). The Haigis or Holladay II formula 
was used for most of the lens calculation and all eyes were 
targeted for emmetropia.
Postoperatively, patients were evaluated at 1 day, 1 week, 
1 month, and 3 months by a qualified optometrist. At each 
visit, refraction, CDVA, UDVA, and UNVA were measured. 
At follow-up visits, patients were required to complete a 
purpose-developed satisfaction questionnaire (Table S1). It 
was self-administered by the patient using a password-protected 
and secure computer terminal in an isolated area of the clinic. 
The questionnaire responses were stored in the secured central 
database, which is compliant with ISO 27001 for information 
security management systems. All response fields used a Likert 
scale to obtain the patient’s preferences or degree of agreement. 
A 3 months postoperative questionnaire was completed in all 
patients and used for analysis. In some patients, we were able 
to retrieve a preoperative questionnaire and calculate the change 
in visual phenomena symptoms, or difficulties performing tasks 
requiring close-up and distance vision. Although the number 
of patients with both pre- and postoperative questionnaires 
was only approximately 50% in each category (Table S2), we 
include this analysis for illustrative purpose.
Three months postoperative data are presented for 
refractive/visual outcomes, whereas complication rates were 
calculated from all available exams.
IOLs
All patients had the Lentis Mplus IOL with 3.0 D near 
addition implanted at least in one eye. In eyes with corneal 
astigmatism less than 1.50 D, non-toric IOL (Lentis Mplus 
LS-313 MF30; Oculentis GmbH) was used and a toric IOL 
was implanted in eyes with corneal astigmatism 1.50 D or 
more (model Lentis Mplus Toric LU-313 MF30T; Oculentis 
GmbH). All patients had their non-dominant eye treated first 
and a lens with 3.0 D near addition was implanted in all 
Clinical Ophthalmology 2017:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1571
rle younger vs older presbyopes
cases. Following the first eye surgery, patients’ symptoms 
were evaluated and a decision was made regarding which 
lens would be the most appropriate for their dominant eye. 
If a patient had no significant issues, an IOL with the same 
reading strength was implanted in their dominant eye. 
Patients with intermediate vision issues or moderate visual 
phenomena usually proceeded with a low near addition IOL 
(1.50 D) in their second eye. Some patients with severe visual 
phenomena selected a monofocal IOL for their dominant eye, 
or decided not to proceed with second eye surgery at all.
Table 1 shows IOL types implanted in second eyes of 
patients in each age category. The majority of patients pro-
ceeded with the same IOL in the second eye (Lentis Mplus) 
or with an IOL of a similar design with the same near addition 
(Lentis MplusX). A small percentage of patients had an IOL 
with a lower reading add, different design of multifocal IOL 
or a monofocal IOL implanted in the second eye, or did not 
proceed with surgery in the second eye (Table 1).
The Lentis Mplus IOL, used in the majority of eyes in 
this study, is a refractive, non-rotational symmetric lens with 
an overall length of 12.0 mm, optic diameter of 6.0 mm, 
and a plate haptic design. It is composed of a hydrophilic 
acrylic material with a hydrophobic surface (Benz25 UV). 
This IOL combines an aspheric distance vision zone with a 
sector-shaped near vision zone with +3.00 D add.
Surgical technique
The procedures were performed at five surgical centers 
across the UK by 14 experienced surgeons. Incisions were 
made on the steepest corneal meridian to neutralize corneal 
astigmatism unless this was impossible due to patient 
anatomy. After phacoemulsification using the AMO 
Whitestar Signature platform (Johnson & Johnson Vision 
Care, Inc, Santa Ana, CA, USA), the IOL was inserted in 
the capsular bag using the Viscoject 2.2 injector (Medicel, 
Wolfhalden, Switzerland). Surgery in the second eye was 
usually performed 1 week later.
Postoperatively, patients were instructed to instill one 
drop of levofloxacin 0.5%, four times daily for 2 weeks, 
one drop of dexamethasone 0.1%, four times daily for 
2 weeks, and one drop of ketorolac trometamol 0.5%, four 
times daily for 1 month.
Patients who did not achieve emmetropia following 
lens implantation were offered an enhancement procedure 
(typically laser vision correction) once the refractive stability 
was achieved, no earlier than 3 months postoperatively. 
Refractive/visual outcomes presented in this study are prior 
to any enhancement procedure.
Statistical analysis
All data were analyzed with Microsoft Office Excel 2007 
program (Microsoft Corporation, Redmond, WA, USA) and 
STATISTICA (Dell StatSoft, Tulsa, OK, USA). One-way 
analysis of variance (ANOVA) was used to compare all 
continuous variables between age groups and a chi square 
test was used to compare proportions. A P-value of 0.05 or 
less was considered statistically significant.
Results
Four age groups were delineated as follows: 45–49 years, 
50–54 years, 55–59 years, and 60–65 years. There were 
320 randomly selected patients in each group who met 
Table 1 IOL types in first and second eyes 
45–49 years 50–54 years 55–59 years 60–64 years
IOL in first eye: lentis Mplus with 3.0 D near add in all cases 
(model ls-313 MF30 [non-toric] or lU-313 MF30T [toric])
IOL in second eye: (number of eyes [%])
Lentis Mplus with 3.0 D near add
(model ls-313 MF30 [non-toric] or lU-313 MF30T [toric]) 250 (78.1%) 248 (77.5%) 235 (73.4%) 251 (78.4%)
Lentis MplusX with 3.0 D near add
(model ls-313 MF30 [non-toric] or lU-313 MF30T [toric]) 45 (14.1%) 40 (12.5%) 50 (15.6%) 33 (10.3%)
Lentis Mplus with low near add (+1.5 or +2.0 D)
(model ls-313 MF15 or ls-313 MF20) 13 (4.1%) 15 (4.7%) 26 (8.1%) 24 (7.5%)
Other multifocal IOL 3 (0.9%) 2 (0.6%) 4 (1.3%) 4 (1.3%)
Monofocal IOL 9 (2.8%) 12 (3.8%) 3 (0.9%) 8 (2.5%)
Did not proceed with second eye
(not an intention) 0 (0%) 1 (0.3%) 2 (0.6%) 0 (0%)
Did not proceed with second eye
(unhappy with first eye) 0 (0%) 2 (0.6%) 0 (0%) 0 (0%)
Abbreviation: iOl, intraocular lens.
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the selection criteria. The number of eyes in each group 
ranged from 637–640, depending on whether the patients 
all had second eye surgery or not. All groups were well 
matched on preoperative sphere and cylinder. Table 2 
shows preoperative and postoperative refractive and visual 
outcomes of the four age categories. Most of the preoperative 
variables were comparable between the four groups. Figure 1 
presents the distribution of preoperative manifest spherical 
equivalent (MSE).
Refractive outcomes
Three months postoperatively, the percentage of patients 
within 0.50 D of emmetropia was as follows: group A: 84.4%, 
group B: 86.8%, group C: 85.7%, group D: 85.8% (P=0.67). 
The proportion of eyes within 1.0 D of emmetropia was 
96.1% in group A, 97.8% in group B, 97.3% in group C, and 
97.5% in group D (P=0.27). There was no statistically sig-
nificant difference in the mean postoperative sphere, cylinder 
or MSE (Table 2). Figure 2 shows refractive outcomes for 
all age categories.
Uncorrected visual acuity
Figures 3 and 4 display postoperative distance and near visual 
acuity. The percentage of eyes that achieved monocular 
UDVA 20/20 or better was 75.2% in group A, 78.2% in 
group B, 77.9% in group C, and 74.8% in group D (P=0.35). 
Similarly, there was no statistically significant difference in 
patients achieving binocular UDVA 20/20 or better (group A: 
91.6%, group B: 93.7%, group C: 91.6%, group D: 88.8%, 
P=0.16).
Monocular UNVA 20/30 or better (approximately J3) was 
achieved in 69.1% in group A, 68.1% in group B, 63.9% in 
group C, and 70.8% in group D (P=0.06). Binocularly, 80.0% 
of patients in group A, 84.7% in group B, 78.8% in group C, 
and 77.8% in group D achieved 20/30 or better UNVA 
(P=0.13). There was no statistically significant difference 
Table 2 Preoperative and postoperative clinical data
Age category 45–49 years 50–54 years 55–59 years 60–65 years P-value
number of patients (eyes) 320 (640) 320 (637) 320 (638) 320 (640)
age
Mean ± sD
47.6±1.3 52.1±1.4 56.9±1.5 62.4±1.7 ,0.01
Female/male 60%/40% 53.5%/46.5% 59.3%/40.7% 58.4%/41.6% 0.08
Preoperative data
sphere
Mean ± sD (range) [D]
+1.75±2.48
(-7.75 to +7.25)
+1.73±2.56
(-10.5 to +7.50)
+1.75±2.56
(-7.25 to +7.5)
+1.67±2.59
(-13.5 to +7.25)
0.93
Cylinder
Mean ± sD (range) [D]
-0.76±0.92
(-7.00 to 0.00)
-0.69±0.85
(-7.50 to 0.00)
-0.75±0.76
(-6.00 to 0.00)
-0.79±0.84
(-5.50 to 0.00)
0.18
Mse
Mean ± sD (range) [D]
+1.37±2.49
(-8.38 to +6.25)
+1.39±2.61
(-10.63 to +7.25)
+1.37±2.53
(-8.5 to +7.00)
+1.27±2.63
(-15.25 to +6.50)
0.85
CDVa
Mean ± sD (range) [logMar]
-0.06±0.05
(-0.18 to 0.00)
-0.06±0.05
(-0.18 to 0.00)
-0.06±0.04
(-0.18 to 0.00)
-0.05±0.06
(-0.18 to 0.00)
0.01
Postoperative data
sphere
Mean ± sD (range) [D]
+0.12±0.45
(-2.00 to +2.75)
+0.15±0.41
(-2.00 to +1.25)
+0.16±0.44
(-1.75 to +1.75)
+0.15±0.43
(-2 to +2.25)
0.28
Cylinder
Mean ± sD (range) [D]
-0.38±0.45
(-4.25 to 0.00)
-0.36±0.40
(-2.25 to 0.00)
-0.37±0.42
(-2.25 to 0.00)
-0.39±0.43
(-2.25 to 0.00)
0.57
Mse
Mean ± sD (range) [D]
-0.07±0.43
(-2.13 to +1.38)
-0.03±0.41
(-2.38 to +1.25)
-0.02±0.43
(-2.13 to +1.63)
-0.05±0.4
(-2.13 to +1.25)
0.11
Monocular UDVa
Mean ± sD (range) [logMar]
0.00±0.12
(-0.18 to 0.80)
-0.01±0.11
(-0.18 to 0.80)
0.00±0.11
(-0.2 to 0.60)
0.01±0.12
(-0.18 to 0.70)
0.10
Binocular UDVa
Mean ± sD (range) [logMar]
-0.05±0.08
(-0.18 to 0.4)
-0.06±0.07
(-0.18 to 0.3)
-0.05±0.08
(-0.18 to 0.3)
-0.05±0.08
(-0.18 to 0.52)
0.09
Monocular UnVa
Mean ± sD (range) [logMar]
0.21±0.16
(-0.3 to 0.8)
0.21±0.15
(-0.08 to 0.9)
0.22±0.16
(-0.08 to 0.9)
0.21±0.17
(-0.3 to 1.0)
0.57
Binocular UnVa
Mean ± sD (range) [logMar]
0.16±0.13
(-0.3 to 0.7)
0.16±0.12
(-0.1 to 0.8)
0.17±0.13
(-0.10 to 0.78)
0.17±0.14
(-0.3 to 0.76)
0.36
Monocular CDVa
Mean ± sD (range) [logMar]
-0.05±0.06
(-0.18 to 0.3)
-0.06±0.06
(-0.18 to 0.4)
-0.05±0.06
(-0.2 to 0.4)
-0.05±0.07
(-0.18 to 0.4)
0.03
Abbreviations: Mse, manifest spherical equivalent; UDVa, uncorrected distance visual acuity, UnVa, uncorrected near visual acuity; CDVa, corrected distance 
visual acuity.
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in the mean postoperative monocular or binocular UDVA 
or UNVA (Table 2) between the four groups.
Corrected visual acuity
Figure 5 depicts the change in pre- to postoperative CDVA. 
Three months postoperatively, 3.1% of eyes in group A, 2.8% 
in group B, 1.9% in group C, and 3.6% in group D (P=0.31) 
had CDVA reduced by two lines or more.
Of all eyes that lost two or more lines of CDVA in 
group A, only two eyes had CDVA worse than 20/25 (one 
due to posterior capsular opacification [PCO], one due to 
poor quality tear film). Seventeen of 20 eyes that lost two or 
more lines of CDVA at 3 months had 20/20 or better CDVA 
at the final visit.
Of all eyes that lost two or more lines of CDVA in group B, 
only one eye had CDVA worse than 20/25 (due to PCO). 
??
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Figure 1 Distribution of preoperative manifest spherical equivalent.
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Figure 2 refractive outcomes: distribution of 3 month postoperative manifest spherical equivalent.
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Seventeen of 18 eyes that lost two or more lines of CDVA at 
3 months had 20/20 or better CDVA at the final visit.
Of all eyes that lost two or more lines of CDVA in group C, 
six eyes had CDVA worse than 20/25 (four due to PCO, one 
due to poor quality tear film, and one for unexplained reason). 
Nine of 12 eyes that lost two or more lines of CDVA at 
3 months had 20/20 or better CDVA at the final visit.
Of all eyes that lost two or more lines of CDVA in group D, 
three eyes had CDVA worse than 20/25 (one due to PCO, 
one due to iritis, and one due to corneal Descemet folds). 
??????????????? ??????????????? ??????????????? ???????????????
??
???
??
??
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????? ????? ????? ?????
????? ????? ????? ?????
????? ????? ????? ?????
?????????? ????? ?????
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Figure 3 Cumulative monocular uncorrected distance visual acuity.
Note: Follow-up 3 months.
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Figure 4 Cumulative monocular uncorrected near visual acuity.
Note: Follow-up 3 months.
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Twenty-one of 23 eyes that lost two or more lines of CDVA 
at 3 months had 20/20 or better CDVA at the final visit.
Patient-reported outcomes
Patient-reported outcomes were tracked with a standardized, 
confidentially administered questionnaire, as described in 
the methods section. Table S1 summarizes outcomes for all 
questionnaire items. General satisfaction with vision was 
comparable between groups and the percentage of satisfied/
very satisfied patients was close to 90% in each group.
There was no statistically significant difference in visual 
phenomena between age groups. In most categories, up to 
10% of patients experienced significant visual phenomena 
(score of 6 or 7), which is not unexpected in the early post-
operative time period, and typically improves over time with 
neuroadaptation.
No statistically significant difference in dry eye symp-
toms was found, with only a small percentage of patients 
(1.3% to 3.8%) experiencing significant dry eye symptoms 
at 3 months.
Questions related to the quality of distance vision (night 
driving, outdoor activities, sport) and near vision also had 
comparable outcomes between age groups. Between 7.0% 
to 11.3% of patients had significant difficulty with night 
driving, 1.9% to 3.4% had significant difficulties with tasks 
requiring close-up vision, and as little as 0.6% to 1.3% had 
significant vision-related difficulty taking part in sport or 
outdoor activities.
Table S2 shows the change in preoperative to postopera-
tive scores. Both preoperative and postoperative question-
naires were available in approximately 50% of patients in 
each category. Preoperatively, patients rated their symptoms 
with their usual spectacle/contact lens wear. Postoperatively, 
patients assessed their symptoms without any corrective 
lenses. The majority of patients had unchanged or increased 
visual phenomena symptoms, night driving difficulties, 
and dry eye symptoms. Difficulties with near and distance 
activities were mostly unchanged, or improved postopera-
tively. The change in the visual phenomena symptoms or 
difficulties with night driving, distance and near activities was 
not statistically significant between age groups (Table S2).
Lens explants
Table 3 shows the incidence of lens explants in each age 
category. The difference in number of patients requiring lens 
explant due to quality of vision issues was not statistically 
significant (1.3% of patients in group A, 0.3% in group B, 
0.9% in group C, and 0.3% in group D, P=0.57). If the 
explant rates are calculated on per-eye basis, the percent-
ages are as follows: group A 0.6%, group B 0.2%, group C 
0.6%, group D 0.3% (P=0.48) All explants due to quality of 
vision were monocular – in all cases, explant of IOL in one 
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Figure 5 Comparison of preoperative and postoperative corrected distance visual acuity.
Note: Follow-up 3 months.
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Table 3 iOl explants
Age category 45–49 years 50–54 years 55–59 years 60–64 years
IOL explant due to quality of vision issues
(secondary iOl: monofocal or low near add multifocal iOl)
4 eyes (0.6%) of
4 patients (1.3%)
1 eye (0.2%) of
1 patient (0.3%)
2 eyes (0.3%) of
2 patients (0.6%)
1 eye (0.2%) of 
1 patient (0.3%)
IOL exchange due to near vision issues
(secondary iOl: different type of multifocal iOl)
– – – 1 eye (0.2%) of 
1 patient (0.3%)
IOL exchange for other reasons
(IOL opacification)
– – 2 eyes (0.3%) of
1 patient (0.3%)
–
Total number of iOl explants 4 eyes (0.6%) of
4 patients (1.3%)
1 eye (0.2%) of
1 patient (0.3%)
4 eyes (0.6%) of
3 patients (0.9%)
2 eyes (0.3%) of 
2 patients (0.6%)
Abbreviation: iOl, intraocular lens.
eye (mostly dominant eye) sufficiently alleviated patient’s 
symptoms and explant of multifocal IOL from second eye 
was not necessary.
Bilateral IOL opacification in group C (Table 2) was 
observed in a 58-year old female with a Lentis Mplus MF30 
LS-313 IOL implant. Apart from a history of sciatica with no 
regular medications taken for this condition, the patient was 
reported to be in good health. Right eye IOL opacification 
was first noted 1 year postoperatively, and left eye 2 years 
postoperatively. Both IOLs were successfully exchanged to 
a multifocal IOL of different material, and the UDVA was 
20/16 in each eye at the last available appointment.
Postoperative complications
Table 4 summarizes postoperative complication rates in the 
four age groups. Of all patients, 76.3% (976 patients) were 
available for a minimum of 6 months follow-up and 45.6% 
(584 patients) were available for a minimum of 12 months 
follow-up.
All cases of corneal edema were transient and cleared 
within the first postoperative week. In all patients with 
elevated intraocular pressure (IOP), IOP increase was noted 
in the early postoperative period and returned to preoperative 
level within the first postoperative month.
All patients with cystoid macular edema (CME) had only 
one episode. All but one of these cases responded to the 
treatment with topical steroids/nonsteroidal anti-inflammatory 
drops and oral acetazolamide. One patient required more 
prolonged management, as discussed in the following 
paragraph. The occurrence of CME was not statistically 
significant between groups.
The case of the prolonged unilateral CME occurred 
in a 56-year old male who underwent RLE for hyperopia 
(+2.50 D). Late-onset CME in this patient was first noted 
1 year after surgery, reducing CDVA to 20/40. The patient 
initially responded to treatment and macular thickness 
significantly reduced, however, one small cyst remained and 
required management for a further 10 months. This patient 
also developed a small area of drusen temporal to the macula 
and was still under investigation at the time of this study. His 
CDVA was 20/25 at the last available follow-up.
Postoperative iritis was the only complication that was 
statistically significant in one of the age groups (50–54 years). 
Most of the patients who developed iritis had a single epi-
sode, apart from two patients: a 51-year old male with four 
episodes up to 6 months postoperatively, and a 56-year old 
female with two episodes within 3 months postoperatively. 
All cases of iritis responded to topical steroid treatment.
Table 4 Postoperative complications
45–49 years
number of eyes [%]
50–54 years
number of eyes [%]
55–59 years
number of eyes [%]
60–65 years
number of eyes [%]
P-value
Mean follow-up ± sD
(months)
12.4±8.4 12.1±9.0 12.2±8.3 12.9±8.5 0.24
Corneal abrasion 0 [0] 4 [0.6] 6 [0.9] 5 [0.8] 0.13
Corneal edema 4 [0.6] 2 [0.3] 6 [0.9] 7 [1.1] 0.38
elevated intraocular pressure 3 [0.5] 0 [0] 1 [0.2] 3 [0.5] 0.28
Cystoid macular edema 3 [0.5] 4 [0.6] 5 [0.8] 3 [0.5] 0.86
iritis 7 [1.1] 19 [3] 5 [0.8] 9 [1.4] 0.008
retinal detachment 0 [0] 0 [0] 0 [0] 1 [0.2] 0.39
endophthalmitis 0 [0] 0 [0] 0 [0] 0 [0] –
Posterior capsular opacification
(Underwent nd:Yag capsulotomy)
74 [11.6]
(54 [8.4])
62 [9.7]
(49 [7.7])
60 [9.4]
(46 [7.2])
62 [9.7]
(47 [7.3])
0.56
(0.84)
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There was one case of unilateral RD (left eye) in a 61-year 
old male with low myopia preoperatively (-0.75 D sphere 
with -0.25 D cylinder) and an axial length of 22.38 mm. 
Inferior RD occurred 1 year after RLE. The patient had good 
outcome following RD repair, and his unaided vision in the 
affected eye eventually returned to 20/16.
The incidence of postoperative PCO and the percentage 
of patients requiring Nd:YAG capsulotomy was comparable 
between age groups.
Discussion
Although more and more surgeons are opting to perform RLE 
on presbyopes younger than 50 years,12–14 to our knowledge, 
no study has specifically compared the visual, refractive, and 
quality of life outcomes among different age categories of 
RLE patients. Younger presbyopes are more active, working-
age patients with high visual requirements for near and 
intermediate vision. They may also have higher quality of 
distance vision requirements (eg, for night driving, outdoor 
activities, and sport) than the older patients. Additionally, 
patients who have not been presbyopic for many years 
(younger patients) may not fully appreciate the frustration 
of near vision loss to the same extent as older presbyopes. 
These older presbyopes have been dependent on near vision 
correction for a longer time and may be more likely to accept 
compromise in quality of vision for near vision gain. On the 
other hand, older patients may have slower visual recovery 
or an increased risk of complications, either of which could 
influence postoperative satisfaction.
In terms of clinical outcomes, comparable results 
were achieved in postoperative sphere, cylinder, and MSE 
(Table 2) and a similar percentage of eyes achieved emmetro-
pia (Figure 2). Although the difference in preoperative or 
postoperative CDVA was statistically significant (Table 2), 
the difference was minimal (0.01 logMAR – less than one 
letter on Snellen visual acuity chart) and clinically irrelevant. 
Despite this slight difference in CDVA, all four groups had 
comparable postoperative uncorrected distance and near 
visual acuity (Table 2). The difference in loss of two or 
more lines of CDVA at the 3 months visit was not statisti-
cally significant between groups, and in most cases, CDVA 
returned to 20/20 or better by the final visit.
Quality of vision, night vision phenomena, and loss of 
contrast sensitivity are the most common reasons for dis-
satisfaction with multifocal IOLs.15–17 To date, no study 
considered age as a possible factor for increased/decreased 
satisfaction with multifocal lens implants. The IOL used 
in the majority of eyes in this study was a non-rotational 
symmetric refractive multifocal IOL, and its characteristics 
and visual phenomena specific to this lens design have been 
previously described.18–22 The IOL is known to provide good 
contrast sensitivity,18–20 which is attributable to the presence 
of only one transition zone between the distance and near 
vision zone. This, in theory, could reduce the source of scat-
tering and aberrations.18–21 Although the near vision with 
refractive non-rotationally symmetric IOLs is not as good 
as with some diffractive or hybrid refractive-diffractive 
IOLs,14,19 it provides some depth of focus and a range of 
near to intermediate vision.18–21 Some studies attributed the 
intermediate vision to the induction of primary coma,18–21 
which can negatively impact on the quality of image.
Despite the hypothesis that younger patients could be 
more sensitive to photic phenomena, there was no statistically 
significant difference in visual phenomena or night driving 
difficulties reported by patients of different age categories. 
Most of the patients had little or no difficulties performing 
tasks requiring close-up vision (Table S1). Between 1.9% 
and 3.4% of patients reported significant difficulty with 
close-up vision. The difference between groups was again 
not statistically significant. The percentage of patients having 
significant difficulty with outdoor activities ranged between 
0.6% and 1.3%, and there was no statistically significant 
difference between groups.
The incidence of lens explant in this study was very 
low and comparable between groups (Table 3). In the 
literature, the most common reasons for IOL explants are 
lens dislocation, incorrect IOL power, dissatisfaction with 
image quality (photic phenomena, contrast sensitivity) 
or IOL opacification17,23,24 In this study, the percentage of 
patients requiring a lens explant due to dissatisfaction with 
image quality was higher in younger patients (1.3% in 
group A: 45–49 years, as opposed to 0.6% or less in remaining 
categories). However, this difference did not reach statistical 
significance. We observed one case of bilateral IOL opaci-
fication in a 58-year old patient originally implanted with 
Lentis Mplus LS-313 MF30 lens, which was successfully 
explanted. No cases of IOL dislocation or IOL tilt occurred 
in this study, which is mostly due to the IOL design used in 
most of the patients (plate haptic non-rotational symmetric 
lens), that is known to have considerably better stability than 
C-loop haptic lens of the same manufacturer.14,22
One of the reasons why RLE is considered controversial 
in younger presbyopes is the possibility of RD, especially in 
patients with longer axial lengths. The reported risk of RD 
following cataract/RLE in highly myopic eyes (in studies 
with a minimum of 2 years follow-up) is 1.5% to 8.1%.6–11 
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It is also important to note, that most of the reported cases of 
RD were in patients in pre-presbyopic age range (less than 
40 years),6–9 which is different than our dataset. Although 
only a small percentage of eyes (less than 3% in each age 
category) had preoperative MSE less than -6.0 D, and most 
of them were treated 2 or more years ago, none of them 
developed an RD. Interestingly, the only case of RD in this 
study was observed in a 61-year old patient with an axial 
length of 22.38 mm, which would normally be considered as 
a low risk for RD. It is still, however, advisable to carefully 
counsel and perform a thorough preoperative vitreo-retinal 
examination in younger patients with incomplete posterior 
vitreous detachment. All other postoperative complications 
were comparable between age groups, except for incidence 
of iritis, which was higher in age category 50–54 years. One 
would expect higher complication rates in older patients, but 
this was not confirmed in this study.
Limitations
One of the limitations of this study was that retrospective 
data were used for analyses. However, it would prove 
difficult to conduct a study on such large scale prospec-
tively, and it would likely result in a much lower number 
of patients in each category. Postoperative follow-up in 
some patients was not long enough to accurately assess 
long-term complications, although most of the complica-
tions specific to RLE (eg, macular or corneal edema, iritis, 
raised IOP, endophthalmitis, etc)14 tend to occur during 
early follow-ups. Although the questionnaire used in this 
study was found effective for reporting subjective outcomes 
of refractive procedures,14,25,26 use of a well-established, 
validated quality of life instrument could also add to the 
value of this study. It would also be interesting to com-
pare data samples stratified by axial length, however, in 
our experience, patient-reported outcomes are mostly 
dependent on patients’ preoperative refractive status, 
rather than axial length. Therefore, the stratification of data 
samples in this paper was based on preoperative refraction.
In conclusion, RLE in different age categories resulted 
in similar clinical outcomes and patient satisfaction rates. 
As long as all the precautions are taken to minimize the 
risk of sight-threatening complications, RLE can be safely 
performed in younger presbyopic patients. Most of the 
patients in this study had refractive error within the limits 
of keratorefractive procedures (Figure 1), but elected to 
undergo RLE to achieve complete spectacle independence. 
New trends in intraocular surgery, such as introduction of 
femtosecond lasers to cataract surgery,3,4 micro-incision 
surgery,3,4 or use of prophylactic intracameral antibiotics 
to prevent endopthalmitis,5 immensely improved the safety 
profile of this procedure, hence, phacoemulsification with 
implantation of IOL is no longer restricted only to patients 
with cataractous crystalline lens. Preoperative consultation 
and discussion of the optical side effects remain one of the 
most important factors in preoperative patient selection.
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Supplementary materials
Table S1 Postoperative patient-reported outcomes according to age category
Age category 45–49 years
(n=320 patients)
50–54 years
(n=320 patients)
55–59 years
(n=320 patients)
60–65 years
(n=320 patients)
P-value
Thinking about your vision during the last week, how satisfied are you with your vision? 
(1= very satisfied, 2= satisfied, 3= neither, 4= dissatisfied, 5= very dissatisfied)
Satisfied (score 1 & 2)
neither (score 3)
Dissatisfied (score 4 & 5)
87.5%
6.9%
5.6%
86.9%
5.0%
8.1%
89.4%
6.9%
3.8%
89.4%
4.7%
5.9%
0.26
Would you recommend vision correction surgery to your friends and relatives?
Yes/no 91.9%/8.1% 93.1%/6.9% 94.4%/5.6% 92.8%/7.2% 0.66
Has surgery improved your quality of life?
Yes/no 91.6%/8.4% 91.9%/8.1% 92.8%/7.2% 91.6%/8.4% 0.93
If you had to do it over, would you have vision correction surgery again?
Yes/no 91.3%/8.8% 94.1%/5.9% 94.4%/5.6% 93.8%/6.3% 0.37
Think about your vision during the last week. Please rate the degree of difficulty you experienced with each of the visual 
symptoms/dry eyes.
(Measured on discrete scale from 1= no difficulty to 7= severe difficulty).
Starburst
No or little difficulty
Moderate difficulty
Significant difficulty
61.3%
32.8%
5.9%
60.0%
30.0%
10.0%
56.6%
36.6%
6.9%
62.2%
31.3%
6.6%
0.26
Glare
No or little difficulty
Moderate difficulty
Significant difficulty
59.7%
32.2%
8.1%
57.2%
32.5%
10.3%
56.6%
36.3%
7.2%
57.8%
35.0%
7.2%
0.69
Halo
No or little difficulty
Moderate difficulty
Significant difficulty
58.8%
33.1%
8.1%
58.4%
30.9%
10.6%
59.1%
33.1%
7.8%
62.5%
31.3%
6.3%
0.57
Ghosting/double vision
No or little difficulty
Moderate difficulty
Significant difficulty
75.9%
19.7%
4.4%
72.5%
22.2%
5.3%
72.5%
23.1%
4.4%
75.6%
20.0%
4.4%
0.90
Dry eyes
No or little difficulty
Moderate difficulty
Significant difficulty
72.8%
24.7%
2.5%
69.7%
26.6%
3.8%
72.8%
25.9%
1.3%
67.8%
29.4%
2.8%
0.40
No or little difficulty (score 0, 1), Moderate difficulty (score 3, 4, 5), Significant difficulty (score 6, 7)
Because of your eyesight, how much difficulty do you have with the following activities?
(1= No difficulty, 2= A little difficulty, 3= Moderate difficulty, 4= A lot of difficulty, 5= never try to do this because of my vision, 6= never do this for 
other reasons)
Driving at night
No or little difficulty
Moderate difficulty
Significant difficulty
73.2%
15.7%
11.2%
71.8%
16.8%
11.3%
72.5%
16.8%
10.7%
73.9%
19.1%
7.0%
0.55
Doing work or hobbies that require you to see well up close, such as cooking, fixing things around the house, sewing, using hand 
tools, or working with a computer
No or little difficulty
Moderate difficulty
Significant difficulty
91.2%
6.0%
2.8%
89.3%
7.8%
2.8%
90.9%
7.2%
1.9%
89.7%
6.9%
3.4%
0.88
Taking part in active sports or other outdoor activities that you enjoy (like hiking, swimming, aerobics, team sports, or jogging)
No or little difficulty
Moderate difficulty
Significant difficulty
95.2%
3.5%
1.3%
95.1%
4.2%
0.6%
96.6%
2.7%
0.7%
96.3%
3.0%
0.7%
0.88
No or little difficulty (score 0, 1), Moderate difficulty (score 3), Significant difficulty (score 4, 5)
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Table S2 Patient-reported outcomes: difference between postoperative and preoperative scores
Age category 45–49 years
(n=146 patients)
50–54 years
(n=153 patients)
55–59 years
(n=162 patients)
60–65 years
(n=161 patients)
P-value
Think about your vision during the last week. Please rate the degree of difficulty you experienced with each of the visual 
symptoms/dry eyes.
(Measured on discrete scale from 1= no difficulty to 7= severe difficulty).
Starburst
Worse
Unchanged
Better
20.5%
78.8%
0.7%
22.9%
75.8%
1.3%
24.1%
75.3%
0.6%
19.9%
77.6%
2.5%
0.71
Glare
Worse
Unchanged
Better
19.9%
78.8%
1.4%
23.5%
74.5%
2.0%
22.8%
76.5%
0.6%
18.6%
78.9%
2.5%
0.76
Halo
Worse
Unchanged
Better
22.6%
75.3%
2.1%
22.2%
77.8%
0.0%
22.2%
77.2%
0.6%
21.7%
77.6%
0.6%
0.63
Ghosting/double vision
Worse
Unchanged
Better
15.1%
82.9%
2.1%
12.4%
87.6%
0.0%
11.7%
87%
1.2%
16.1%
81.4%
2.5%
0.43
Dry eyes
Worse
Unchanged
Better
13.0%
84.2%
2.7%
14.4%
83.7%
2.0%
12.3%
86.4%
1.2%
16.8%
81.4%
1.9%
0.87
Worse: increase in symptoms by more than 2 scores
Unchanged: preoperative minus postoperative score 0±2 scores
Better: decrease in symptoms by more than 2 scores
Because of your eyesight, how much difficulty do you have with the following activities? 
(1= No difficulty, 2= A little difficulty, 3= Moderate difficulty, 4= A lot of difficulty, 5= never try to do this because of my vision, 6= never do this for 
other reasons)
Driving at night
Worse
Unchanged
Better
21.7%
72.7%
5.6%
17%
76.9%
6.1%
17.8%
73.0%
9.2%
12.0%
81.7%
6.3%
0.35
Doing work or hobbies that require you to see well up close, such as cooking, fixing things around the house, sewing, using hand 
tools, or working with a computer
Worse
Unchanged
Better
6.3%
72.7%
21%
4.6%
69.1%
26.3%
1.3%
75%
23.8%
3.8%
74.8%
21.4%
0.34
Taking part in active sports or other outdoor activities that you enjoy (like hiking, swimming, aerobics, team sports, or jogging)
Worse
Unchanged
Better
2.9%
79.7%
17.4%
1.3%
80.5%
18.1%
0.0%
74.3%
25.7%
1.4%
79.7%
18.9%
0.25
Worse: increase in symptoms by more than 1 score
Unchanged: preoperative minus postoperative score 0±1 score
Better: decrease in symptoms by more than 1 score
Notes: Patients rated their preoperative symptoms/difficulties with best spectacle/contact lens correction; postoperative symptoms were rated without any spectacle/
contact lens correction. 
